- First medicine approved in the U.S. specifically for the treatment of aTTP, a rare blood-clotting disorder
- Cablivi is the first U.S. approval for Sanofi's new rare blood disorders franchise
PR Newswire
BRIDGEWATER, N.J., Feb. 6, 2019
PR Newswire
BRIDGEWATER, N.J., Feb. 6, 2019
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey